CLEVELAND, March 29, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van
Bokkelen, Chairman and CEO, will present a corporate overview at the 16th Annual Needham Healthcare Conference at The
Westin New York Grand Central Hotel in New York City. The presentation is scheduled for Tuesday, April 4, 2017 at 12:10 pm
ET.
Investors interested in arranging a meeting with the Company's management during this conference should contact
the conference coordinator.
A live webcast of the presentation can be accessed by visiting ‘Events & Presentations’ in the Investors Section
on the Company's website at www.athersys.com. An archived replay of the webcast will be available for 90 days on the Company's
website after the conference.
About Athersys
Athersys is an international biotechnology company engaged in the development of therapeutic products designed
to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a
patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular,
and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine
product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy
toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.
ATHX-G
Contact: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 bjlehmann@athersys.com David Schull Russo Partners, LLC Tel: (212) 845-4271 or (858) 717-2310 David.schull@russopartnersllc.com Investor Contact: Peter Vozzo Westwicke Partners (443) 213-0505 or (443) 377-4767 (mobile) Peter.vozzo@westwicke.com
